zenocutuzumab
pozelimab
matuzumab
teplizumab
panitumumab
antimonoclonal
ozogamicin
carlumab
inotuzumab ozogamicin
drozitumab
agonistic monoclonal antibody
monoantibody
-mab
lexatumumab
cibisatamab
bococizumab
polyclonal
-xizu-
hyperimmunoglobulin
immunoglobulin E
sibrotuzumab
immunoadsorbent
alacizumab
chromobody
atezolizumab
oportuzumab monatox
-lim-
lucatumumab
durvalumab
polyantigenic
antisubstance
xenoantibody
aritox
nofetumomab
multiantigenic
tabalumab
glucoincretin
dalotuzumab
immunoantigen
horseradish peroxidase
-toxa-
pritumumab
brentuximab
faralimomab
antihuman
ABO antibodies
heterophile antibody
heterophil antibody
seroconversion
Forssman antibody